Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1995 Jun;39(6):1324–1328. doi: 10.1128/aac.39.6.1324

Noncytotoxic combinations of topical antimicrobial agents for use with cultured skin substitutes.

S T Boyce 1, G D Warden 1, I A Holder 1
PMCID: PMC162735  PMID: 7574524

Abstract

Cultured skin grafts are destroyed more easily than split-thickness skin grafts by common burn wound organisms, including gram-negative and gram-positive bacteria and fungi. To increase the survival and engraftment of cultured skin grafts, formulations of antimicrobial agents were tested for cytotoxicity to cultured human keratinocytes and fibroblasts and for activity against common organisms from burn wounds. On the basis of previous studies, a base formulation containing neomycin (40 micrograms/ml), polymyxin B (700 U/ml), and mupirocin (40 micrograms/ml) was prepared, to which ciprofloxacin (20 micrograms/ml) or norfloxacin (20 micrograms/ml) and amphotericin B (0.25 microgram/ml) or nystatin (100 U/ml) were added. Toxicity to cultured human cells was determined by the growth response of cell cultures (n = 6) to each drug combination over 4 days. Activity against clinical isolates (n = 40) of Staphylococcus aureus, Pseudomonas aeruginosa, other gram-negative bacteria, and Candida spp. was determined by the wet disc assay. Analysis of variance testing showed no significant differences in the growth of keratinocytes or fibroblasts under control or experimental conditions. Medium without antimicrobial agents was not effective against any of the 40 microbial strains tested. The base formulation was effective against all bacterial strains tested but against none of the fungi, while all experimental formulations were effective against all microbial strains tested. These findings suggest that neomycin, mupirocin, and polymyxin B may be combined with a quinolone and an antimycotic agent to provide broad antimicrobial activity for a formulation for topical use with cultured skin on burns. However, the formulations described here are strictly experimental and are not recommended for clinical use without further evaluation.

Full Text

The Full Text of this article is available as a PDF (242.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barillo D. J., Nangle M. E., Farrell K. Preliminary experience with cultured epidermal autograft in a community hospital burn unit. J Burn Care Rehabil. 1992 Jan-Feb;13(1):158–165. doi: 10.1097/00004630-199201000-00035. [DOI] [PubMed] [Google Scholar]
  2. Boyce S. T., Greenhalgh D. G., Kagan R. J., Housinger T., Sorrell J. M., Childress C. P., Rieman M., Warden G. D. Skin anatomy and antigen expression after burn wound closure with composite grafts of cultured skin cells and biopolymers. Plast Reconstr Surg. 1993 Apr;91(4):632–641. doi: 10.1097/00006534-199304000-00010. [DOI] [PubMed] [Google Scholar]
  3. Boyce S. T., Ham R. G. Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture. J Invest Dermatol. 1983 Jul;81(1 Suppl):33s–40s. doi: 10.1111/1523-1747.ep12540422. [DOI] [PubMed] [Google Scholar]
  4. Boyce S. T., Holder I. A. Selection of topical antimicrobial agents for cultured skin for burns by combined assessment of cellular cytotoxicity and antimicrobial activity. Plast Reconstr Surg. 1993 Sep;92(3):493–500. doi: 10.1097/00006534-199309000-00018. [DOI] [PubMed] [Google Scholar]
  5. Boyce S. T., Medrano E. E., Abdel-Malek Z., Supp A. P., Dodick J. M., Nordlund J. J., Warden G. D. Pigmentation and inhibition of wound contraction by cultured skin substitutes with adult melanocytes after transplantation to athymic mice. J Invest Dermatol. 1993 Apr;100(4):360–365. doi: 10.1111/1523-1747.ep12471822. [DOI] [PubMed] [Google Scholar]
  6. Boyce S. T., Warden G. D., Holder I. A. Cytotoxicity testing of topical antimicrobial agents on human keratinocytes and fibroblasts for cultured skin grafts. J Burn Care Rehabil. 1995 Mar-Apr;16(2 Pt 1):97–103. doi: 10.1097/00004630-199503000-00002. [DOI] [PubMed] [Google Scholar]
  7. Boyce S. T., Williams M. L. Lipid supplemented medium induces lamellar bodies and precursors of barrier lipids in cultured analogues of human skin. J Invest Dermatol. 1993 Aug;101(2):180–184. doi: 10.1111/1523-1747.ep12363678. [DOI] [PubMed] [Google Scholar]
  8. Compton C. C., Hickerson W., Nadire K., Press W. Acceleration of skin regeneration from cultured epithelial autografts by transplantation to homograft dermis. J Burn Care Rehabil. 1993 Nov-Dec;14(6):653–662. doi: 10.1097/00004630-199311000-00010. [DOI] [PubMed] [Google Scholar]
  9. Conti B., Pavanetto F., Genta I. Use of polylactic acid for the preparation of microparticulate drug delivery systems. J Microencapsul. 1992 Apr-Jun;9(2):153–166. doi: 10.3109/02652049109021231. [DOI] [PubMed] [Google Scholar]
  10. Cooper M. L., Boyce S. T., Hansbrough J. F., Foreman T. J., Frank D. H. Cytotoxicity to cultured human keratinocytes of topical antimicrobial agents. J Surg Res. 1990 Mar;48(3):190–195. doi: 10.1016/0022-4804(90)90212-k. [DOI] [PubMed] [Google Scholar]
  11. Cuono C. B., Langdon R., Birchall N., Barttelbort S., McGuire J. Composite autologous-allogeneic skin replacement: development and clinical application. Plast Reconstr Surg. 1987 Oct;80(4):626–637. doi: 10.1097/00006534-198710000-00029. [DOI] [PubMed] [Google Scholar]
  12. Fox C. L., Jr, Rappole B. W., Stanford W. Control of pseudomonas infection in burns by silver sulfadiazine. Surg Gynecol Obstet. 1969 May;128(5):1021–1026. [PubMed] [Google Scholar]
  13. Gallico G. G., 3rd, O'Connor N. E., Compton C. C., Kehinde O., Green H. Permanent coverage of large burn wounds with autologous cultured human epithelium. N Engl J Med. 1984 Aug 16;311(7):448–451. doi: 10.1056/NEJM198408163110706. [DOI] [PubMed] [Google Scholar]
  14. Greco F., de Palma L., Spagnolo N., Rossi A., Specchia N., Gigante A. Fibrin-antibiotic mixtures: an in vitro study assessing the possibility of using a biologic carrier for local drug delivery. J Biomed Mater Res. 1991 Jan;25(1):39–51. doi: 10.1002/jbm.820250104. [DOI] [PubMed] [Google Scholar]
  15. Green H., Kehinde O., Thomas J. Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proc Natl Acad Sci U S A. 1979 Nov;76(11):5665–5668. doi: 10.1073/pnas.76.11.5665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hansbrough J. F., Boyce S. T., Cooper M. L., Foreman T. J. Burn wound closure with cultured autologous keratinocytes and fibroblasts attached to a collagen-glycosaminoglycan substrate. JAMA. 1989 Oct 20;262(15):2125–2130. [PubMed] [Google Scholar]
  17. Hansbrough J. F. Current status of skin replacements for coverage of extensive burn wounds. J Trauma. 1990 Dec;30(12 Suppl):S155–S160. doi: 10.1097/00005373-199012001-00030. [DOI] [PubMed] [Google Scholar]
  18. Hansbrough J. F., Doré C., Hansbrough W. B. Clinical trials of a living dermal tissue replacement placed beneath meshed, split-thickness skin grafts on excised burn wounds. J Burn Care Rehabil. 1992 Sep-Oct;13(5):519–529. doi: 10.1097/00004630-199209000-00004. [DOI] [PubMed] [Google Scholar]
  19. Heggers J. P., Robson M. C., Herndon D. N., Desai M. H. The efficacy of nystatin combined with topical microbial agents in the treatment of burn wound sepsis. J Burn Care Rehabil. 1989 Nov-Dec;10(6):508–511. doi: 10.1097/00004630-198911000-00009. [DOI] [PubMed] [Google Scholar]
  20. Heimbach D., Luterman A., Burke J., Cram A., Herndon D., Hunt J., Jordan M., McManus W., Solem L., Warden G. Artificial dermis for major burns. A multi-center randomized clinical trial. Ann Surg. 1988 Sep;208(3):313–320. doi: 10.1097/00000658-198809000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Holder I. A., Knoll C. A., Wesselman J. Norfloxacin and silver-norfloxacin as topical antimicrobial agents: results of in vitro susceptibility testing against bacteria and Candida sp isolated from burn patients. J Burn Care Rehabil. 1986 Nov-Dec;7(6):479–483. [PubMed] [Google Scholar]
  22. Holder I. A. The wet disc antimicrobial solution assay. An in vitro method to test efficacy of antimicrobial solutions for topical use. J Burn Care Rehabil. 1989 May-Jun;10(3):203–208. [PubMed] [Google Scholar]
  23. Hull B. E., Finley R. K., Miller S. F. Coverage of full-thickness burns with bilayered skin equivalents: a preliminary clinical trial. Surgery. 1990 May;107(5):496–502. [PubMed] [Google Scholar]
  24. Lindberg R. B., Moncrief J. A., Mason A. D., Jr Control of experimental and clinical burn wounds sepsis by topical application of sulfamylon compounds. Ann N Y Acad Sci. 1968 Aug 14;150(3):950–960. doi: 10.1111/j.1749-6632.1968.tb14747.x. [DOI] [PubMed] [Google Scholar]
  25. Lineaweaver W., McMorris S., Soucy D., Howard R. Cellular and bacterial toxicities of topical antimicrobials. Plast Reconstr Surg. 1985 Mar;75(3):394–396. doi: 10.1097/00006534-198503000-00016. [DOI] [PubMed] [Google Scholar]
  26. MOYER C. A., BRENTANO L., GRAVENS D. L., MARGRAF H. W., MONAFO W. W., Jr TREATMENT OF LARGE HUMAN BURNS WITH 0.5 PER CENT SILVER NITRATE SOLUTION. Arch Surg. 1965 Jun;90:812–867. doi: 10.1001/archsurg.1965.01320120014002. [DOI] [PubMed] [Google Scholar]
  27. McCauley R. L., Linares H. A., Pelligrini V., Herndon D. N., Robson M. C., Heggers J. P. In vitro toxicity of topical antimicrobial agents to human fibroblasts. J Surg Res. 1989 Mar;46(3):267–274. doi: 10.1016/0022-4804(89)90069-3. [DOI] [PubMed] [Google Scholar]
  28. Monafo W. W., West M. A. Current treatment recommendations for topical burn therapy. Drugs. 1990 Sep;40(3):364–373. doi: 10.2165/00003495-199040030-00004. [DOI] [PubMed] [Google Scholar]
  29. Nacucchio M. C., Di Rocco P. H., Sordelli D. O. Liposomes as carriers for antibiotics. Targeted Diagn Ther. 1990;3:337–354. [PubMed] [Google Scholar]
  30. Pittelkow M. R., Scott R. E. New techniques for the in vitro culture of human skin keratinocytes and perspectives on their use for grafting of patients with extensive burns. Mayo Clin Proc. 1986 Oct;61(10):771–777. doi: 10.1016/s0025-6196(12)64815-0. [DOI] [PubMed] [Google Scholar]
  31. Saltz R., Dimick A., Harris C., Grotting J. C., Psillakis J., Vasconez L. O. Application of autologous fibrin glue in burn wounds. J Burn Care Rehabil. 1989 Nov-Dec;10(6):504–507. doi: 10.1097/00004630-198911000-00008. [DOI] [PubMed] [Google Scholar]
  32. Strock L. L., Lee M. M., Rutan R. L., Desai M. H., Robson M. C., Herndon D. N., Heggers J. P. Topical Bactroban (mupirocin): efficacy in treating burn wounds infected with methicillin-resistant staphylococci. J Burn Care Rehabil. 1990 Sep-Oct;11(5):454–459. [PubMed] [Google Scholar]
  33. Tamada J., Langer R. The development of polyanhydrides for drug delivery applications. J Biomater Sci Polym Ed. 1992;3(4):315–353. doi: 10.1163/156856292x00402. [DOI] [PubMed] [Google Scholar]
  34. Warden G. D., Saffle J. R., Kravitz M. A two-stage technique for excision and grafting of burn wounds. J Trauma. 1982 Feb;22(2):98–103. doi: 10.1097/00005373-198202000-00004. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES